Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Paclitaxel in Recurrent Cervical and Uterine Tumors
NCT00626561Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2008
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Cervical Cancer (CC), uterine cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
Cervical Cancer (CC)uterine cancer
Beyond the preview
Go deeper on NCT00626561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626561.